文献速递临床试验与 GCP流行病学与生物统计

富钾低钠盐替代品改善南非索韦托青少年及其家庭钠钾比与降低血压的疗效:随机对照试验研究方案

The efficacy of a low-sodium salt substitute enriched with potassium to improve sodium-to-potassium ratio and reduce blood pressure in adolescents and their families in Soweto, South Africa: study protocol for randomised controlled trial.
PubMed 文献 · Trials · 2025-11-04

该研究方案为一项1期双盲随机对照试验,计划在南非索韦托纳入600名13-19岁青少年及其主要照护者,按家庭随机分配接受富钾低钠盐替代品或传统食盐(氯化钠)16周,评估尿钠钾比与血压变化;方案已获威特沃特斯兰德大学医学人类研究伦理委员会批准(M221056),并在泛非临床试验注册中心注册(PACTR202306727520808,2023年6月9日)。

要点

  • 计划纳入600名13-19岁青少年及其主要照护者,按家庭随机分配。
  • 干预为富钾低钠盐替代品对比传统食盐,周期16周。
  • 主要评估尿钠钾比与血压,并做肾功能安全筛查。

核心结论

  • 作者认为,所获结果按其所知将是非洲人群中首个探讨富钾低钠盐替代品改善尿钠钾比和血压疗效的研究。

研究设计与样本

  • 研究方案为1期双盲随机对照试验,计划纳入600名13-19岁青少年及其主要照护者,均居住于南非索韦托。
  • 青少年及其家庭被随机分配接受富钾低钠盐替代品或传统食盐(氯化钠),为期16周,并去除所有其他家用盐产品。
  • 人体测量与问卷数据在0周和16周采集,点尿样本与血压在0、4、12和16周采集,基线时对家庭成员进行肾功能安全筛查。
  • 方案获威特沃特斯兰德大学医学人类研究伦理委员会批准(M221056),注册号为PACTR202306727520808(2023年6月9日)。

局限性

  • 原文指出,非洲人群尤其是青少年中的证据缺乏。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: The burden of cardiovascular disease in Sub-Saharan Africa has increased in recent years, and high blood pressure is the leading cause. One established risk factor for hypertension and cardiovascular disease is dietary salt intake. The World Health Organisation has highlighted low-sodium salt substitutes (LSSS) as a potential method to lower sodium intake. LSSS enriched with potassium may additionally support improving sodium-potassium balance. Studies in India and China have investigated the impact of LSSS on reducing sodium intake and the risk of stroke and hypertension in adults. However, evidence in African populations, and in particular youth, is lacking. As such, this protocol describes a phase 1 double-blinded randomised controlled trial to assess the efficacy of a potassium-enriched LSSS compared to traditional salt to improve urinary sodium-to-potassium ratio and blood pressure in African adolescents and their families. METHODS: We will enrol 600 adolescents (13-19 years old) and their primary caregivers living in Soweto, South Africa. Adolescents and their households will be randomised to receive a LSSS or traditional table salt (NaCl) for a 16-week period. All other household salt products will be removed. Anthropometrics and questionnaire data will be collected at 0 and 16 weeks. Spot urine samples and blood pressure will be collected at 0, 4, 12 and 16 weeks. Safety screening for kidney function will be conducted on household members at baseline. The trial protocol received ethics approval from the University of Witwatersrand Medical Human Research Ethics Committee (M221056). DISCUSSION: The obtained results will, to the best of our knowledge, be the first in an African population to provide insights into the efficacy of a potassium-enriched LSSS in improving urinary sodium-to-potassium ratio and blood pressure. TRIAL REGISTRATION: This trial is registered with the Pan African Clinical Trials Registry ( https://pactr.samrc.ac.za ); identifier: PACTR202306727520808 (09 June 2023).

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Crouch SH, Ware LJ, Norris SA, et al. The efficacy of a low-sodium salt substitute enriched with potassium to improve sodium-to-potassium ratio and reduce blood pressure in adolescents and their families in Soweto, South Africa: study protocol for randomised controlled trial. Trials. 2025. PMID: 41188917. doi:10.1186/s13063-025-09184-z

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。